SUBSTRATE SPECIFICITY OF CYTOCHROME P450 2D6 GENETIC VARIANTS

被引:0
|
作者
van der Lee, M. [1 ]
Guchelaar, H. [1 ]
Swen, J. [1 ]
机构
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PI-015
引用
收藏
页码:S9 / S9
页数:1
相关论文
共 50 条
  • [1] The endocannabinoid anandamide is a substrate of cytochrome P450 2D6
    Snider, Natasha Tasheva
    Sridar, Chitra
    Hollenberg, Paul
    FASEB JOURNAL, 2008, 22
  • [2] Cytochrome P450 2D6
    Owen, Ryan P.
    Sangkuhl, Katrin
    Klein, Teri E.
    Altman, Russ B.
    PHARMACOGENETICS AND GENOMICS, 2009, 19 (07): : 559 - 562
  • [3] Cytochrome P450 2D6 genetic polymorphisms of ugandans
    Miura, I.
    Saito, K.
    Obua, C.
    Abbo, C.
    Kaneko, S.
    Tateishi, T.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 103 - 103
  • [4] A refilled substrate model for human cytochrome P450 2D6
    deGroot, MJ
    Bijloo, GJ
    Martens, BJ
    vanAcker, FAA
    Vermeulen, NPE
    CHEMICAL RESEARCH IN TOXICOLOGY, 1997, 10 (01) : 41 - 48
  • [5] Identification of genetic variants of human cytochrome P450 2D6 with impaired mitochondrial targeting
    Sangar, Michelle Cook
    Anandatheerthavarada, Hindupur K.
    Martin, Martha V.
    Guengerich, F. Peter
    Avadhani, Narayan G.
    MOLECULAR GENETICS AND METABOLISM, 2010, 99 (01) : 90 - 97
  • [6] Allosteric effects of cytochrome P450 reductase on cytochrome P450 2D6
    Roberts, GCK
    Modi, S
    Gilham, DE
    Sutcliffe, MJ
    Lian, LY
    Primrose, WU
    Wolf, CR
    FASEB JOURNAL, 1997, 11 (09): : A789 - A789
  • [7] Substrate Specificity, Inhibitors and Regulation of Human Cytochrome P450 2D6 and Implications in Drug Development
    Zhou, Shu-Feng
    Liu, Jun-Ping
    Lai, Xin-Sheng
    CURRENT MEDICINAL CHEMISTRY, 2009, 16 (21) : 2661 - 2805
  • [8] Comparison of Cytochrome P450 2D6 and Variants in Terms of Drug Oxidation Rates and Substrate Inhibition
    Niwa, Toshiro
    Murayama, Norie
    Yamazaki, Hiroshi
    CURRENT DRUG METABOLISM, 2011, 12 (05) : 412 - 435
  • [9] Cytochrome P450 2D6 variants and their association with breast cancer survival
    Abraham, J. E.
    Maranian, M.
    Driver, K.
    Greenberg, D.
    Shah, M. N.
    Earl, H. M.
    Dunning, A. M.
    Pharoah, P. P. D. P.
    Caldas, C.
    CANCER RESEARCH, 2009, 69 (02) : 229S - 229S
  • [10] The Endocannabinoid Anandamide Is a Substrate for the Human Polymorphic Cytochrome P450 2D6
    Snider, Natasha T.
    Sikora, Matthew J.
    Sridar, Chitra
    Feuerstein, Thomas J.
    Rae, James M.
    Hollenberg, Paul F.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 327 (02): : 538 - 545